EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece

Nomikos, N., Naoum, P., Athanasakis, K. & Kyriopoulos, I.

(2024). EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece. Value in Health, 27(12 Supplement), S149. https://doi.org/10.1016/j.jval.2024.10.759

Copy

Item Type	Article
Departments	LSE > Academic Departments > Health Policy
DOI	10.1016/j.jval.2024.10.759
Date Deposited	25 Feb 2025
URI	https://researchonline.lse.ac.uk/id/eprint/127401

Explore Further

Kyriopoulos, Ilias-Ioannis

RA Public aspects of medicine
RM Therapeutics. Pharmacology

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=lse-pure-import-candidates&SrcAuth=WosAPI&KeyUT=WOS:001414964800077&DestLinkType=FullRecord&DestApp=WOS_CPL

Full text not available from this repository.

Downloads

View more statistics

EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece

Explore Further

Export as